Paper7500751
Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
Bloemenkamp KW and 4 others. Lancet, 1995. Cited by 506 papers, by iCite.
Cite this record
ConductScience Library. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Papers, record 7500751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7500751
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Contraceptives, Oral, Combined | Major topic |
| Factor V | Major topic |
| Mutation | Major topic |
| Progestins | Major topic |
| Thrombophlebitis | Major topic |
| Adolescent | |
| Adult | |
| Desogestrel | |
| Ethinyl Estradiol | |
| Female | |
| Humans | |
| Middle Aged | |
| Risk Factors |
Source PubMed
Comments and corrections7
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 7500743 | Third-generation oral contraceptives: how risky? | https://conductscience.org/library/papers/7500743 | PubMed |
| Comment in | 8596297 | Safety of combined oral contraceptive pills. | https://conductscience.org/library/papers/8596297 | PubMed |
| Comment in | 8596298 | Safety of combined oral contraceptive pills. | https://conductscience.org/library/papers/8596298 | PubMed |
| Comment in | 8596299 | Safety of combined oral contraceptive pills. | https://conductscience.org/library/papers/8596299 | PubMed |
| Comment in | 8598719 | Factor V Leiden and third-generation oral contraceptives. | https://conductscience.org/library/papers/8598719 | PubMed |
| Comment in | 10560680 | Risk of idiopathic venous thromboembolism in users of progestagens alone. | https://conductscience.org/library/papers/10560680 | PubMed |
| Comment on | 7500748 | Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. | https://conductscience.org/library/papers/7500748 | PubMed |
Cited by74
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 506 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39728272 | Ischemic Stroke in Women: Understanding Sex-Specific Risk Factors, Treatment Considerations, and Outcomes. | J Cardiovasc Dev Dis | 2024 | https://conductscience.org/library/papers/39728272 | PubMed |
| 39358019 | Beyond Birth Control: The Neuroscience of Hormonal Contraceptives. | J Neurosci | 2024 | https://conductscience.org/library/papers/39358019 | PubMed |
| 38707879 | Evolution of Oral Contraceptive Pills. | J Obstet Gynaecol India | 2024 | https://conductscience.org/library/papers/38707879 | PubMed |
| 37612053 | Cerebral venous sinus thrombosis: changing trends in the incidence, age and gender (findings from the CMC Vellore CVT registry). | Stroke Vasc Neurol | 2024 | https://conductscience.org/library/papers/37612053 | PubMed |
| 37235737 | Hormones and thrombosis: the dark side of the moon. | Blood Transfus | 2024 | https://conductscience.org/library/papers/37235737 | PubMed |
| 34956081 | Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk. | Front Endocrinol (Lausanne) | 2021 | https://conductscience.org/library/papers/34956081 | PubMed |
| 32551357 | The French pill scare and the reshaping of social inequalities in access to medical contraceptives. | SSM Popul Health | 2020 | https://conductscience.org/library/papers/32551357 | PubMed |
| 32431379 | Systematic Review of Hormonal Contraception and Risk of Venous Thrombosis. | Linacre Q | 2018 | https://conductscience.org/library/papers/32431379 | PubMed |
| 32342502 | The joint effect of genetic risk factors and different types of combined oral contraceptives on venous thrombosis risk. | Br J Haematol | 2020 | https://conductscience.org/library/papers/32342502 | PubMed |
| 31772081 | Do Norwegian providers comply with national recommendations when prescribing combined oral contraceptives to starters? A cohort study. | BMJ Open | 2019 | https://conductscience.org/library/papers/31772081 | PubMed |
| 29388678 | A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception. | Int J Gynaecol Obstet | 2018 | https://conductscience.org/library/papers/29388678 | PubMed |
| 28580443 | Reduced Prothrombinase Inhibition by Tissue Factor Pathway Inhibitor Contributes to the Factor V Leiden Hypercoagulable State. | Blood Adv | 2017 | https://conductscience.org/library/papers/28580443 | PubMed |
| 28202862 | Venous Thromboembolism Due to Oral Contraceptive Intake and Spending Nights in a Vehicle -A Case from the 2016 Kumamoto Earthquakes. | Intern Med | 2017 | https://conductscience.org/library/papers/28202862 | PubMed |
| 28049361 | Oral Contraceptives and HRT Risk of Thrombosis. | Clin Appl Thromb Hemost | 2018 | https://conductscience.org/library/papers/28049361 | PubMed |
| 27975098 | Endotoxaemia-augmented murine venous thrombosis is dependent on TLR-4 and ICAM-1, and potentiated by neutropenia. | Thromb Haemost | 2017 | https://conductscience.org/library/papers/27975098 | PubMed |
| 27642556 | Suppression of liver Apo E secretion leads to HDL/cholesterol immaturity in rats administered ethinylestradiol. | FEBS Open Bio | 2016 | https://conductscience.org/library/papers/27642556 | PubMed |
| 27164970 | Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study. | BMJ | 2016 | https://conductscience.org/library/papers/27164970 | PubMed |
| 26500457 | Family history of venous thromboembolism is a risk factor for venous thromboembolism in combined oral contraceptive users: a nationwide case-control study. | Thromb J | 2015 | https://conductscience.org/library/papers/26500457 | PubMed |
| 26149025 | New insights into the biology of tissue factor pathway inhibitor. | J Thromb Haemost | 2015 | https://conductscience.org/library/papers/26149025 | PubMed |
| 24751717 | Estimate of venous thromboembolism and related-deaths attributable to the use of combined oral contraceptives in France. | PLoS One | 2014 | https://conductscience.org/library/papers/24751717 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| F5 | 2153 | PubTator's text mining | https://conductscience.org/library/genes/2153 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7500751
GET https://conductscience.org/api/papers/v1/7500751/cited_by?page=2